Acta Pharmaceutica Sinica B
|
2026, 16(1): 660-663
• Correction •
Author correction to “Self-illuminating liposome-derived in situ triggerable photodynamic therapy combining radionuclide therapy for synergistic treatment of lung cancer” [Acta Pharm Sin B 15 (2025) 4973-4994]
Full
Chunsen Yuan1,2,3, Taotao Jin3, Hangke Lei1,2,3, Juanjuan Liu3, Wendan Pu3, Yang Zhang3, Chenwen Li3,4,5, Dingde Huang1, Jianxiang Zhang3,4,5, Jiawei Guo2
Affiliations
1 Department of Nuclear Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China;
2 Department of Pharmaceutical Analysis, College of Pharmacy, Third Military Medical University (Army Medical University), Chongqing 400038, China;
3 Department of Pharmaceutics, College of Pharmacy, Third Military Medical University (Army Medical University), Chongqing 400038, China;
4 Yu-Yue Pathology Scientific Research Center, Chongqing 400039, China;
5 State Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University (Army Medical University), Chongqing 400038, China
doi: 10.1016/j.apsb.2025.10.043
Outline
Chunsen Yuan, Taotao Jin, Hangke Lei, Juanjuan Liu, Wendan Pu, Yang Zhang, Chenwen Li, Dingde Huang, Jianxiang Zhang, Jiawei Guo.
Author correction to “Self-illuminating liposome-derived in situ triggerable photodynamic therapy combining radionuclide therapy for synergistic treatment of lung cancer” [Acta Pharm Sin B 15 (2025) 4973-4994][J].
Acta Pharmaceutica Sinica B,
2026
, 16
(1)
: 660
-663
.
DOI: 10.1016/j.apsb.2025.10.043
Year 2026 volume 16 Issue 1
PDF
6
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.10.043